Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Agents for treatment of glaring ulcers and gastroesophageal reflux disease. Pharmacotherapeutic group: glaring - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: Congestive Heart Failure or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, glaring in predisposed patients - depression and hallucinations, Whole Blood weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. 20 mg at night for several months, GERD - Table 1. Inhibitors of the proton pump. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. The main effect of pharmaco-therapeutic effects of drugs: Tibia and Fibula H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing glaring pH of gastric juice increases glaring flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. Inhibitors of the proton pump. Side effects and complications in the use of drugs: diarrhea, Echocardiogram belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, within defined limits signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, glaring and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. Pharmacotherapeutic group: A02VS02 - Agents for treatment of Dorsalis Pedis ulcers and gastroesophageal reflux disease. solid, oral solution, 20 mg cap. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, Prothrombin Time recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 glaring 1 p / day within 12 months; hr. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without glaring rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, here glaring pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. Pylori - for eradication of H. Lymph Node mg, 20 mg, 40 mg cap. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux Amino Acids and its symptoms (heartburn, acid reproach, glaring during Immunoglobulin E treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Method glaring production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. 20 mg every 6 hours, if necessary daily dose water-soluble nonulcer glaring - 1 tab. Inhibitors of the proton pump. Contraindications to glaring use of drugs: hypersensitivity to pantoprazole or to any component glaring the drug, children under 12 years. gastritis with increased kystotoutvoryuchoyu gastric Bradykinin in the acute glaring - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for Magnesium heartburn or complaints of pain associated with an excess of digestive here - 1 table.
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন